Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy.
about
Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studiesThe impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancerThe prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancerThe prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancerSerum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival timePrognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.A comparison of DNA methylation specific droplet digital PCR (ddPCR) and real time qPCR with flow cytometry in characterizing human T cells in peripheral bloodPreoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy.Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survivalELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis.Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer.Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer.Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer.Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer.Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer.The prognostic value of the systemic inflammatory score in patients with unresectable metastatic colorectal cancer.Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells
P2860
Q33762117-50305925-7D10-4B85-A8EF-61CAA639D2E5Q34646737-0DA9C148-8F2C-46B5-A06D-8F3B3DE81A6EQ35692835-C8E5E643-BE72-42B2-B689-9F43318EC086Q35701024-D87A5E9D-F2A9-476F-9BF2-763B001AF55BQ35772513-284CD7E9-049E-4947-BE3B-D99D298F0B55Q36050510-9E8A2FBA-09DB-4F5E-8A81-6D4AC020B0F5Q36054506-B5B5AAA1-CE9C-483C-A658-CFB13A388C40Q36057482-7B2C7ED2-A9B0-4B0B-B969-85F4CFCF8F28Q36072579-2029C3DF-EE39-4F5E-AC70-D3754F3F4034Q36213455-4C0F8446-7161-49E9-ACE2-20141959CE3DQ36390876-40510636-0B3F-4712-8BD7-542CB599080EQ36467544-8CD4B57D-EB36-499D-BEBE-BD35686B2718Q36729590-0221FF79-7320-4E8E-BDD2-678E5E68BBE4Q36895039-EC0434B6-AACA-4D8A-84F3-1290E8FD7479Q37989867-FECD579D-5BF6-481A-ADB4-EA33D23E8F0EQ38413705-9E8EDECF-2EB4-4D7D-B97D-8CA3C7043C30Q38518401-E280B204-CA5E-4047-9C7E-7B46D70728FCQ39070636-C86C61FB-365C-456D-8D58-48F7CE0F834CQ40435555-860481E4-14EC-425D-AAAA-E6AACC2584E8Q41491972-B123AEC2-F86C-43D6-AEF4-65522E524FD0Q42316366-FEC3CA70-B66F-4D18-9292-006F548BFCE8Q45763605-84747E72-E28E-4EAC-A614-7D48575F2542Q47141034-DC5E9AA4-8764-4F89-A004-12770739B356Q47986796-30020FA2-3000-4CAD-852B-040E689C0B27Q49730740-B6C41A78-CF54-4B55-BFC8-D4441EEE507FQ51063023-A226E3DF-1499-4A52-8353-F17579274404Q55354894-E23EFAC1-7B3D-4CB1-95D4-02036FDFE91FQ57700802-F9ED0E53-4480-476E-8E5F-8247880B1A40
P2860
Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@en
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@nl
type
label
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@en
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@nl
prefLabel
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@en
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@nl
P2093
P2860
P921
P1476
Pre-treatment lymphopenia as a ...... tients receiving chemotherapy.
@en
P2093
G Thibault
P2860
P2888
P304
P356
10.1007/S00280-011-1610-3
P577
2011-03-30T00:00:00Z